Pharmacogenomics in Practice
Pharmacogenomics in Practice
Amina Abubakar, PharmD, AAHIVP, owner of RxClinic Pharmacy, discusses how pharmacogenomics works in her daily practice with patients.
Learn More about Clinical Roles
Latest News

A patient at age 65 with high blood pressure could extend their life by more than a year with intensive treatment focused on a target systolic blood pressure of less than 120 mm Hg.
Each November, members of the chronic obstructive pulmonary disease (COPD) community come together to focus on increasing awareness of the respiratory condition.
Treat Cellulitis
Skin and soft tissue infections (SSTIs), also referred to as skin and skin structure infections, are a relatively common reason for health care visits in both the inpatient and outpatient settings.
New Treatment for Adults with Partial-Onset Seizures
The FDA has approved cenobamate tablets (XCOPRI, SK Life Sciences) for treatment of partial-onset seizures in adults.
FDA Approves Acalabrutinib
Under a new international collaboration, the FDA has granted supplemental approval to acalabrutinib (Calquence, AstraZeneca) for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic leukemia.
The 48-week phase 4 study showed that tocilizumab was more effective than rituximab in patients with rheumatoid arthritis with low B cell levels in synovial tissue.
The Clinical Performance and Quality Measures included 6 performance measures, 6 process quality measures, and a new category of 10 structural quality measures for adults with high blood pressure.
Top news of the day from across the health care landscape.
Drug Shortages
The Food and Drug Administration Safety and Innovation Act was signed into law in 2012, but the crisis continues.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss the benefits of attending NASP during the NASP Annual Meeting in Washington, DC.
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Explore More About Pharmacy Times